Literature DB >> 3132384

Comparative antimicrobial activity of the new macrolide flurithromycin against respiratory pathogens.

C E Nord1, A Lindmark, I Persson.   

Abstract

The activity of flurithromycin against Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, Branhamella catarrhalis and Staphylococcus aureus was determined by the agar dilution method. Flurithromycin showed high activity against Streptococcus pneumoniae, Streptococcus pyogenes and Branhamella catarrhalis (MIC90 = 0.032-0.25 mg/l). Its MIC90 value against Haemophilus influenzae strains was 4.0 mg/l and 16 mg/l against Staphylococcus aureus strains. Flurithromycin has promising antibacterial activity which warrants clinical trials.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3132384     DOI: 10.1007/bf01962180

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  1 in total

1.  In vitro activity of flurithromycin, a novel macrolide antibiotic.

Authors:  G Gialdroni Grassi; R Alesina; C Bersani; A Ferrara; A Fietta; V Peona
Journal:  Chemioterapia       Date:  1986-06
  1 in total
  1 in total

Review 1.  New directions for macrolide antibiotics: structural modifications and in vitro activity.

Authors:  H A Kirst; G D Sides
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.